Article ; Online: Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper Part I: Understanding the basic technologies and apheresis medicine practice models.
2020 Volume 35, Issue 5, Page(s) 460–468
Abstract: ... and Advocacy Committee of the American Society for Apheresis (ASFA) and endorsed by its Board ... adoption of telehealth technologies has been catalyzed by the COVID-19 pandemic as these technologies ... access, advance technical capabilities of apheresis devices, and/or elevate quality performance within TA ...
| Abstract | The wide spread availability and use of sophisticated high-speed telecommunication networks coupled with inexpensive and easily accessible computing capacity have catalyzed the creation of new tools and strategies for healthcare delivery. Such tools and strategies are of value to apheresis medicine (AM) practitioners if they improve delivery of patient care, enhance safety during a therapeutic apheresis (TA) intervention, facilitate care access, advance technical capabilities of apheresis devices, and/or elevate quality performance within TA programs. In the past several years, healthcare delivery systems' adoption of telecommunication technologies has been fostered by organizational financial and quality improvement objectives. More recently, adoption of telehealth technologies has been catalyzed by the COVID-19 pandemic as these technologies enhance both patient and provider safety in an era of social distancing. These changes will also influence the delivery of TA services which now can be generally viewed in a tripartite model format comprised of traditional hospital-based fixed site locales, mobile TA operations and lately an evolving telemedicine remote management model now reffered to as telapheresis (TLA). This communication developed by the Public Affairs and Advocacy Committee of the American Society for Apheresis (ASFA) and endorsed by its Board of Directors, reviews and describes various aspects of established and evolving electronic technologies related to TLA and the practice of AM. In subsequent companion publications, additional aspects to TLA will be explored and ASFA's vision of reasonable, regulatory compliant and high-quality TLA practices will be expounded. |
|---|---|
| MeSH term(s) | Blood Component Removal/methods ; COVID-19/epidemiology ; Humans ; Mobile Health Units ; SARS-CoV-2 ; Societies, Medical ; Telemedicine/methods |
| Language | English |
| Publishing date | 2020-08-17 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 604912-6 |
| ISSN | 1098-1101 ; 0733-2459 |
| ISSN (online) | 1098-1101 |
| ISSN | 0733-2459 |
| DOI | 10.1002/jca.21814 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1831: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.